Comparison of effect of daily versus weekly iron supplementation during pregnancy on lipid peroxidation

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 3, 2009, Pages 438-445

  Bhatla, Neerja ^a,b   Kaul, Nivedita ^b   Lal, Neena ^b   Kriplani, Alka ^b   Agarwal, Nutan ^b   Saxena, Renu ^b   Gupta, Suresh K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Department of Obstetrics and Gynaecology ^*

Author keywords

Intermittent; Iron; Lipid peroxidation; Polymaltose; Pregnancy

Indexed keywords

CALCIUM; FERROUS SULFATE; FOLIC ACID; GLUTATHIONE; HEMOGLOBIN; IRON POLYMALTOSE; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG EFFECT; EPIGASTRIC DISCOMFORT; FEMALE; GESTATION PERIOD; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IRON THERAPY; LABOR; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MATERNAL CARE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

ADULT; BODY MASS INDEX; DIETARY SUPPLEMENTS; FEMALE; FERRIC COMPOUNDS; FOLIC ACID; GESTATIONAL AGE; GLUTATHIONE; HEMOGLOBINS; HUMANS; IRON; LIPID PEROXIDATION; PREGNANCY; PROSPECTIVE STUDIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 67650483089     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00972.x     Document Type: Article

References (30)

1. Ekström EC, Hyder SM, Chowdhury AM et al. Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: disentangling the issues. Am J Clin Nutr 2002 76 : 1392 1400. (Pubitemid 35416577)
2. Gutteridge JM. Iron and free radicals. In : Hallberg L, Asp NG (eds). Iron Nutrition in Health and Disease. London : John Libbey and Co, 1996 239 246.
3. Beard JL. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 2000 71 (5 Suppl 1288S 94S.
4. Lachili B, Hininger I, Faure H et al. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res 2001 83 : 103 110. (Pubitemid 33116441)
5. Wang YP, Walsh SW, Guo JD, Zhang JY. Maternal levels of prostacyclin, thromboxane, vitamin E and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 1991 165 : 1690 1694.
6. Cargnoni A, Gregorini G, Ceconi C, Majorca R, Ferrari R. Lipid peroxidation in normal pregnancy and preeclampsia. Adv Exp Med Biol 1994 366 : 420 421.
7. Karowicz-Bilinska A, Suzin J, Sieroszewski P. Evaluation of oxidative stress indices in treatment of pregnant women with IUGR. Med Sci Monit 2002 8 : CR211 CR216.
8. Ridwan E, Schultink W, Dillon D, Gross R. Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation. Am J Clin Nutr 1996 63 : 884 890. (Pubitemid 26000942)
9. Liu XN, Liu PY. The effectiveness of weekly iron supplementation regimen in improving the iron status of Chinese children and pregnant women. Biomed Environ Sci 1996 9 : 341 347.
10. Young MW, Lupafya E, Kapenda E, Bobrow EA. The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi. Trop Doct 2000 30 : 84 88. (Pubitemid 30182339)
11. Gomber S, Agarwal KN, Mahajan C, Agarwal N. Impact of daily versus weekly hematinic supplementation on anemia in pregnant women. Indian Paediatr 2002 39 : 339 346. (Pubitemid 34415180)
12. Mukhopadhyay A, Bhatla N, Kriplani A, Pandey RM, Saxena R. Daily versus intermittent iron supplementation in pregnant women: hematological and pregnancy outcome. J Obstet Gynaecol Res 2004 30 : 409 417. (Pubitemid 40007520)
13. Knutson MD, Walter PB, Ames BN, Viteri FE. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 2000 130 : 621 628. (Pubitemid 30118081)
14. Tuomainen TP, Nyyssönen K, Sarataho EP, Salonen R, Baumgartner JA, Geisser P. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res 1999 19 : 1121 1132. (Pubitemid 29297738)
15. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984 1 : 1396 1397. (Pubitemid 14122030)
16. Hall ED, Braughler JM. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 1989 6 : 303 313. (Pubitemid 19076496)
17. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989 320 : 915 924. (Pubitemid 19101597)
18. Szczeklik A, Gryglewski RJ, Domagula B, Dworski R, Basista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: Effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 1985 54 : 425 430. (Pubitemid 16252464)
19. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989 161 : 1025 1034. (Pubitemid 19266226)
20. Madazli R, Benian A, Gümüstas K, Uzun H, Ocak V, Aksu F. Lipid peroxidation and antioxidants in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1999 8 : 205 208.
21. Serdar Z, Gür E, Colakoethullarý M, Dewelioethlu O, Sarandöl E. Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 2003 268 : 19 25. (Pubitemid 36717862)
22. Morris JM, Gopaul NK, Endresen MJ et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998 105 : 1195 1199. (Pubitemid 28526203)
23. Regan CL, Levine RJ, Baird DD et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001 185 : 572 578. (Pubitemid 32862541)
24. Karowicz-Bilinska A, Kowalska-Koprek U, Suzin J, Sieroszewski P Analysis of 8- isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR Ginekol Pol 2003 74 : 1137 1142 In Polish PS, Adsul BB, Gundewar K, Desai A. Mumfer (iron polymaltose complex) in the management of anaemia in pregnancy: An Indian study. J Indian Med Assoc 2000 98 : 343 346.
25. Walawalkar SS, Chugh S. A randomized, controlled trial of ferric hydroxide polymaltose complex and ferrous fumarate in anaemia in pregnancy. JAMA India - The Physicians Update 2001 4 : 36 40.
26. Mehta BC. Iron hydroxide polymaltose: Iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy. J Assoc Physicians India 2002 50 : 279 280.
27. Bichile SK, Kumar V. Persistent iron deficiency anaemia. J Assoc Physicians India 2002 50 : 617 618.
28. Hyder SM, Persson LA, Chowdhury AM, Ekström EC. Do side effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 2002 20 : 175 179. (Pubitemid 34884796)
29. Jacobs P, Wood L, Bird AR. Erythrocytes: Better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia. Hematology 2000 5 : 77 83. (Pubitemid 30410508)
30. Johnson G, Jacobs P. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol 1990 18 : 1064 1069.